Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: HSBC Downgrades Shell To Hold From Buy

Wed, 11th Sep 2019 09:31

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

----------

FTSE 100

----------

HSBC CUTS ROYAL DUTCH SHELL TO 'HOLD' ('BUY') - PRICE TARGET 2500 (2780) PENCE

----------

HSBC CUTS BP PRICE TARGET TO 600 (645) PENCE - 'BUY'

----------

JEFFERIES CUTS AVIVA PRICE TARGET TO 502 (520) PENCE - 'BUY'

----------

BARCLAYS RAISES ASHTEAD GROUP PRICE TARGET TO 2430 (2230) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK RAISES ASHTEAD GROUP PRICE TARGET TO 2230 (2050) PENCE - 'HOLD'

----------

INVESTEC CUTS STANDARD CHARTERED TO 'SELL' ('HOLD')

----------

CITIGROUP RAISES ASTRAZENECA PRICE TARGET TO 10000 (7000) PENCE - 'BUY'

----------

BERENBERG RAISES JD SPORTS FASHION PRICE TARGET TO 800 (700) PENCE - 'BUY'

----------

BERENBERG RAISES WPP PRICE TARGET TO 985 (900) PENCE - 'HOLD'

----------

FTSE 250

----------

HSBC RAISES PENNON GROUP PRICE TARGET TO 890 (870) PENCE - 'BUY'

JEFFERIES CUTS AGGREKO PRICE TARGET TO 1150 (1175) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

RBC CUTS CONSORT MEDICAL PRICE TARGET TO 1060 (1130) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS TYMAN PRICE TARGET TO 230 (270) PENCE - 'HOLD'

----------

BERENBERG RAISES DAILY MAIL & GENERAL TRUST PRICE TARGET TO 950 (850) PENCE - 'BUY'

----------

PEEL HUNT INITIATES RENEW HOLDINGS WITH 'BUY' - TARGET 500 PENCE

----------

HSBC RAISES BIFFA PRICE TARGET TO 300 (290) PENCE - 'BUY'

----------

JPMORGAN INITIATES FEVERTREE DRINKS WITH 'OVERWEIGHT' - TARGET 2740 PENCE

----------

JPMORGAN RAISES VECTURA GROUP PRICE TARGET TO 110 (100) PENCE - 'OVERWEIGHT'

----------

More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.